Zerion and Insud to develop Dispersome formulations of drugs
Insud has obtained a global exclusive licence to the first Dispersome drug formulation from Zerion.
Sofgen Pharmaceuticals WP
Do generics producers have what it takes to tackle complex and specialty drugs?
FDA panel deliberates on Covid-19 booster doses as population immunity wanes
Covid-19 update: Pfizer reviews fourth vaccine dose data
Moderna to supply 10.8 million Covid-19 vaccine doses to Colombia
The US agrees to buy additional doses of GSK-Vir’s Covid-19 antibody
3D printing in drug manufacturing: unlocking future possibilities
EU to procure over 200 million doses of Pfizer-BioNTech’s Comirnaty
